LatchBio
Agent Infrastructure for Biology
San Francisco, United States · Founded 2021 · $33.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Total Funding
- $33.0M
About
LatchBio builds AI agent infrastructure for biology, providing a modular platform that orchestrates scientific teams across genomics, single-cell analysis, and bioinformatics workflows. The company bundles its platform with kits and instruments to serve over 300 pharma, biotech, and academic R&D teams worldwide, offering both a public benchmarking suite (benchmarks.bio) and a deployment sandbox (agent.bio) for frontier biology agents. Founded in 2021 and based in San Francisco, LatchBio also operates a biosecurity research division following its acquisition of YC S25 team TwentyTwo.
Summary
LatchBio is a Biotech company based in San Francisco, United States, founded in 2021. It has raised $33.0M in total.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Leading interactive entertainment company and developer of Fortnite, Unreal Engine, and the Epic ...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Cursor is the best way to code with AI, and built to make you extraordinarily productive.
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform